Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pilot Study of Cisplatin, Etoposide, Bleomycin and Escalating Dose Cyclophosphamide Therapy for Children With High Risk Malignant Germ Cell Tumors

NCT00066482 is registered in ClinicalTrials.gov with Children's Oncology Group as lead sponsor.

NCT NCT00066482
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00066482 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pilot Study of Cisplatin, Etoposide, Bleomycin and Escalating Dose Cyclophosphamide Therapy for Children With High Risk Malignant Germ Cell Tumors
Lead sponsor
Children's Oncology Group
Phase
Not applicable
Overall status
Completed
Start date
July 31, 2004
Completion date
Not reported
Enrollment
19 (actual)
Sites
98

Conditions

As the registry lists them; a condition with its own page is linked.

childhood germ cell tumor, extragonadal germ cell tumor